Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigational Study of CX-801 as Monotherapy and in Combination With PD1 Inhibition in Participants With Solid Tumors

NCT06462794 is registered in ClinicalTrials.gov with CytomX Therapeutics as lead sponsor.

NCT NCT06462794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06462794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigational Study of CX-801 as Monotherapy and in Combination With PD1 Inhibition in Participants With Solid Tumors
Lead sponsor
CytomX Therapeutics
Phase
Phase 1
Overall status
Recruiting
Start date
August 28, 2024
Completion date
June 30, 2029
Enrollment
121 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, adult